Navigation Links
Early exposure to bisphenol A might damage the enamel of teeth
Date:6/10/2013

Analysis of the damage shows numerous characteristics that are common with a recently identified pathology of tooth enamel that affects roughly 18% of children between the ages of 6 and 8.

These results have been published in the American Journal of Pathology.

Bisphenol A (BPA) is a chemical compound used in the composition of plastics and resins. It is used for example to manufacture food containers such as bottles or babies' bottles. It is also used for the protective films inside drinks cans and food tins, or as developers on sales receipts. Significant amounts of BPA have also been found in human blood, urine, amniotic liquid and placentas. Recent studies have shown that this industrial compound has adverse effects on the reproduction, development and metabolism of laboratory animals. It is strongly suspected of having the same effects on humans.

As a precautionary measure, the manufacture and commercialisation of babies' bottles containing bisphenol A were prohibited in Europe in January 2011. The prohibition will be extended to all food containers in France as from July 2015.

So this study shows that teeth are the latest in an already long list of victims of BPA. The Inserm researchers have shown that the incisors of rats treated with low daily doses of BPA (5 microgrammes/kg/day) could be damaged by this. This effect has also been observed within a development window of no more than 30 days post-birth in rats, thus demonstrating a range of sensitivity to exposure.

Analysis of these teeth showed numerous characteristics that are common with a tooth enamel pathology known as MIH (Molar Incisor Hypomineralisation) that selectively affects first molars and permanent incisors. This enamel pathology is found in roughly 18% of children between the ages of 6 and 8. Children affected by this pathology present with teeth that are hypersensitive to pain and liable to cavities. It is interesting to note that the period during which these teeth are formed (the first years of life) correspond to the period during which humans are most sensitive to bisphenol A.

Amongst the earliest observations made was the appearance of "white marks" on the incisors of rats treated with endocrine disruptors, one of which was bisphenol A (BPA). The researchers decided to define the characteristics of incisors of rats treated with low doses of BPA and to compare these with the characteristics of teeth in humans suffering from MIH Macroscopic observation of marks on both series of teeth showed similarities, in particular fragile and brittle enamel.

Microscope observation of the enamel showed a significant reduction of the Ca/P and the Ca/C ratios in affected teeth. This leads to mineral depletion, making the teeth more fragile and more liable to cavities. Finally, analysis of the proteins present in the tooth matrix of rats showed an increased quantity of enamelin, a key protein for enamel formation, and a buildup of albumin leading to hypomineralisation. Analysis of the expression of key enamel genes highlighted two BPA target genes: enamelin and kallicrein 4.

According to Sylvie Babajko, the latest author of this article, "Insofar as BPA has the same mechanism of action in rats as in men, it could also be a causal agent of MIH. Therefore, teeth could be used as early markers of exposure to endocrine disruptors acting in the same way as BPA and so could help in early detection of serious pathologies that would otherwise have occurred several years later".


'/>"/>

Contact: Sylvie Babajko
sylvie.babajko@crc.jussieu.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related biology news :

1. Artificial womb unlocks secrets of early embryo development
2. Mid-Atlantic suburbs can expect an early spring thanks to the heat of the big city
3. An early spring drives butterfly population declines
4. Hazy shades of life on early Earth
5. American Society of Plant Biologists honors early career women scientists
6. Early warning system for seizures could cut false alarms
7. A new gene thought to be the cause in early-onset forms of Alzheimers disease
8. Promising developments in early diagnosis and treatment of mesothelioma
9. Early detection techniques offer hope for improved outcomes in lung cancer patients
10. New study links air pollution and early death in the UK
11. Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017 Aviva ... tools, announced the acquisition of GenWay Biotech Incorporated, ... comprehensive service and product offering for both the ... will facilitate growth and enhance capabilities for both ... and ELISA assays will nicely complement ASB,s objective ...
(Date:2/22/2017)...  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company ... products for companion animals, will host a live conference call ... discuss financial results from the fourth quarter and full year ... investors may access the audio webcast or use ... ...
(Date:2/22/2017)...  PrimeVax Immuno-Oncology, Inc. announced today its CEO, ... Biocom Global Life Science Partnering Conference.  The presentation will ... the Torrey Pines Lodge, in San Diego.  ... who have chosen our company, amongst numerous others, to ... and clinical researchers," said Mr. Chen. "In contrast to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... development of precision treatments for neurodegenerative diseases, today announced it has issued a ... approach.” This is one of a series of commentaries from ProMIS’s scientific team ...
Breaking Biology Technology: